Already the dominant producer of rare minerals, Beijing is using export restrictions and its power over state-owned companies to further control access.

After supply chain disruptions that made critical medicines scarce, a federal effort is underway to ensure domestic stocks of pharmaceutical ingredients.

Our supply chains are vulnerable, which means that we are vulnerable.

Under pressure from Chinese competitors, Amazon, Walmart and other U.S. retailers have been exploring ways to avoid tariffs. Could a new Biden administration rule change that?